Vera Pomerantseva, Director of Product Management for RBQM, eClinical Solutions, discusses FDA's shift to a single pivotal trial standard, in an effort to streamline drug development without lowering the scientific bar.
Vera Pomerantseva
Advertisement
Director of Product Management for RBQM at eClinical Solutions
Articles by Vera Pomerantseva
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Releases Open Letter Warning of Potential Safety Risks for Compounded Tirzepatide Plus Vitamin B12
2
What is Shadow AI and How is it Impacting Pharma Companies?
3
Novo Nordisk Responds to FDA’s Warning Letter Regarding 2025 PADE Inspection
4
Agentic AI and the Future of Commercial Excellence in Life Sciences
5